Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eton Pharmaceuticals (ETON) Cash from Operations (2019 - 2025)

Eton Pharmaceuticals' Cash from Operations history spans 7 years, with the latest figure at 12026000.0 for Q3 2025.

  • For Q3 2025, Cash from Operations rose 307.38% year-over-year to 12026000.0; the TTM value through Sep 2025 reached 21310000.0, up 904.71%, while the annual FY2024 figure was 969000.0, 85.78% down from the prior year.
  • Cash from Operations for Q3 2025 was 12026000.0 at Eton Pharmaceuticals, up from 7959000.0 in the prior quarter.
  • Across five years, Cash from Operations topped out at 12026000.0 in Q3 2025 and bottomed at 5117000.0 in Q4 2021.
  • The 5-year median for Cash from Operations is 1223000.0 (2022), against an average of 1576789.47.
  • The largest annual shift saw Cash from Operations skyrocketed 766.94% in 2022 before it tumbled 297.67% in 2024.
  • A 5-year view of Cash from Operations shows it stood at 5117000.0 in 2021, then surged by 155.5% to 2840000.0 in 2022, then crashed by 86.37% to 387000.0 in 2023, then crashed by 297.67% to 765000.0 in 2024, then skyrocketed by 1672.03% to 12026000.0 in 2025.
  • Per Business Quant, the three most recent readings for ETON's Cash from Operations are 12026000.0 (Q3 2025), 7959000.0 (Q2 2025), and 2090000.0 (Q1 2025).